Electromedical Technologies Stock Net Income
| EMED Stock | USD 0.0001 0.0001 50.00% |
As of the 17th of February 2026, Electromedical Technologies shows the Variance of 902.1, mean deviation of 14.46, and Standard Deviation of 30.03. Electromedical Technologies technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Electromedical Technologies variance, as well as the relationship between the maximum drawdown and skewness to decide if Electromedical Technologies is priced favorably, providing market reflects its regular price of 1.0E-4 per share. As Electromedical Technologies appears to be a penny stock we also advise to verify its jensen alpha numbers.
Electromedical Technologies' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Electromedical Technologies' valuation are provided below:Electromedical Technologies does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Electromedical |
Electromedical Technologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Electromedical Technologies' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Electromedical Technologies.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Electromedical Technologies on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Electromedical Technologies or generate 0.0% return on investment in Electromedical Technologies over 90 days. Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pa... More
Electromedical Technologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Electromedical Technologies' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Electromedical Technologies upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.149 | |||
| Maximum Drawdown | 150.0 | |||
| Value At Risk | (50.00) | |||
| Potential Upside | 100.0 |
Electromedical Technologies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Electromedical Technologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Electromedical Technologies' standard deviation. In reality, there are many statistical measures that can use Electromedical Technologies historical prices to predict the future Electromedical Technologies' volatility.| Risk Adjusted Performance | 0.1319 | |||
| Jensen Alpha | 4.34 | |||
| Total Risk Alpha | 2.3 | |||
| Treynor Ratio | 1.41 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Electromedical Technologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Electromedical Technologies February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1319 | |||
| Market Risk Adjusted Performance | 1.42 | |||
| Mean Deviation | 14.46 | |||
| Coefficient Of Variation | 660.77 | |||
| Standard Deviation | 30.03 | |||
| Variance | 902.1 | |||
| Information Ratio | 0.149 | |||
| Jensen Alpha | 4.34 | |||
| Total Risk Alpha | 2.3 | |||
| Treynor Ratio | 1.41 | |||
| Maximum Drawdown | 150.0 | |||
| Value At Risk | (50.00) | |||
| Potential Upside | 100.0 | |||
| Skewness | 2.16 | |||
| Kurtosis | 6.2 |
Electromedical Technologies Backtested Returns
Electromedical Technologies is out of control given 3 months investment horizon. Electromedical Technologies secures Sharpe Ratio (or Efficiency) of 0.14, which denotes the company had a 0.14 % return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-two different technical indicators, which can help you to evaluate if expected returns of 3.33% are justified by taking the suggested risk. Use Electromedical Technologies Mean Deviation of 14.46, variance of 902.1, and Standard Deviation of 30.03 to evaluate company specific risk that cannot be diversified away. Electromedical Technologies holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 3.22, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Electromedical Technologies will likely underperform. Use Electromedical Technologies information ratio, skewness, day typical price, as well as the relationship between the treynor ratio and daily balance of power , to analyze future returns on Electromedical Technologies.
Auto-correlation | -0.07 |
Very weak reverse predictability
Electromedical Technologies has very weak reverse predictability. Overlapping area represents the amount of predictability between Electromedical Technologies time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Electromedical Technologies price movement. The serial correlation of -0.07 indicates that barely 7.0% of current Electromedical Technologies price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.07 | |
| Spearman Rank Test | 0.72 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Electromedical Technologies reported net income of (8.48 Million). This is 102.48% lower than that of the Healthcare sector and 103.56% lower than that of the Medical Devices industry. The net income for all United States stocks is 101.49% higher than that of the company.
Electromedical Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Electromedical Technologies' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Electromedical Technologies could also be used in its relative valuation, which is a method of valuing Electromedical Technologies by comparing valuation metrics of similar companies.Electromedical Technologies is currently under evaluation in net income category among its peers.
Electromedical Fundamentals
| Return On Asset | -1.36 | |||
| Operating Margin | (2.94) % | |||
| Current Valuation | 3.49 M | |||
| Shares Outstanding | 172.88 M | |||
| Shares Owned By Insiders | 11.80 % | |||
| Price To Sales | 1.53 X | |||
| Revenue | 907.36 K | |||
| Gross Profit | 708.13 K | |||
| EBITDA | (5.14 M) | |||
| Net Income | (8.48 M) | |||
| Cash And Equivalents | 65.23 K | |||
| Total Debt | 673.28 K | |||
| Current Ratio | 0.17 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (1.19 M) | |||
| Earnings Per Share | (0.15) X | |||
| Beta | 1.44 | |||
| Market Capitalization | 1.64 M | |||
| Total Asset | 1.4 M | |||
| Retained Earnings | (91.42 M) | |||
| Working Capital | (3.45 M) | |||
| Current Asset | 441 K | |||
| Current Liabilities | 3.9 M | |||
| Net Asset | 1.4 M |
About Electromedical Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Electromedical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Electromedical Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Electromedical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Electromedical Pink Sheet
Electromedical Technologies financial ratios help investors to determine whether Electromedical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Electromedical with respect to the benefits of owning Electromedical Technologies security.